(CIDRAP News) – The Institute of Medicine (IOM) yesterday shared findings of three public opinion panels on antiviral distribution during a flu pandemic, including a nod for establishing diverse alternative strategies and support for Web and cell-phone information.
(CIDRAP News) A study in which N95 respirators strongly outperformed surgical masks in shielding hospital workers from influenza viruses and other microbes is being hailed as a landmark in research on respiratory protection for healthcare workers.
(CIDRAP News) The Institute of Medicine (IOM) today affirmed existing federal guidance that healthcare workers caring for H1N1 influenza patients should wear fit-tested N95 respirators, not just surgical masks, to protect them from the virus.
(CIDRAP News) On the second and final day of an Institute of Medicine (IOM) task force meeting on how to protect healthcare workers from the novel H1N1 virus, experts focused on issues surrounding the effectiveness and practical use of masks and respirators in work settings.
The IOM task force's goal is to make recommendations about how to protect healthcare workers during the H1N1 pandemic.
(CIDRAP News) – With the global outbreak of novel H1N1 influenza (swine flu) entering its fourth week, physicians at emergency rooms, clinics, and hospitals around the United States say they are overwhelmed with "worried well" who have as much as doubled their patient loads.
(CIDRAP News) Seven universities will share $10.9 million in federal funds to study the ability of state and local public health systems to respond to emergencies, the Centers for Disease Control and Prevention (CDC) announced yesterday.
(CIDRAP News) – Proposed pandemic preparedness guidance released by the federal government today recommends that people wear face masks if they have to go into crowds during an influenza pandemic and says critical infrastructure businesses should consider stockpiling antiviral drugs, among various other suggestions.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
Editor's note: This is the first in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.